BATS | ETF
Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements.
The fund invests predominantly in common stock.
Although it may invest across economic sectors, the fund concentrates its investments in health care related industries.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 6.54% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 6.41% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 5.33% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.32% |
| INSM | Insmed Inc | Healthcare | Biotechnology | 4.24% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 4.18% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 3.65% |
| 207940 | Samsung Biologics Co Ltd | Healthcare | Biotechnology | 3.41% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 3.33% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 3.06% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 2.95% |
| ADPT | Adaptive Biotechnologies Corp | Healthcare | Biotechnology | 2.95% |
| CTVA | Corteva Inc | Basic Materials | Agricultural Inputs | 2.79% |
| AZN | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| AZN_old | AstraZeneca PLC | Healthcare | Drug Manufacturers - General | 2.77% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 2.63% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 2.62% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 2.61% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.56% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 2.11% |